{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:16:46Z","timestamp":1778635006224,"version":"3.51.4"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":608,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1111\/bjd.12594","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T15:44:40Z","timestamp":1376927080000},"page":"182-187","source":"Crossref","is-referenced-by-count":26,"title":["A second look at efficacy criteria for onychomycosis: clinical and mycological cure"],"prefix":"10.1093","volume":"170","author":[{"given":"M.","family":"Ghannoum","sequence":"first","affiliation":[{"name":"Center for Medical Mycology; Department of Dermatology; University Hospitals Case Medical Center; Cleveland OH U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Isham","sequence":"additional","affiliation":[{"name":"Center for Medical Mycology; Department of Dermatology; University Hospitals Case Medical Center; Cleveland OH U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Catalano","sequence":"additional","affiliation":[{"name":"Center for Medical Mycology; Department of Dermatology; University Hospitals Case Medical Center; Cleveland OH U.S.A"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,1,13]]},"reference":[{"key":"10.1111\/bjd.12594-BIB0001|bjd12594-cit-0001","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.1992.tb00005.x","article-title":"Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey","volume":"126","author":"Roberts","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12594-BIB0002|bjd12594-cit-0002","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","article-title":"Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions","volume":"133","author":"Elewski","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12594-BIB0003|bjd12594-cit-0003","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2133.1995.tb00722.x","article-title":"Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study","volume":"132","author":"Sais","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12594-BIB0004|bjd12594-cit-0004","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"Ghannoum","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12594-BIB0005|bjd12594-cit-0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/000155502762064665","article-title":"Prevalence of onychomycosis in Iceland: a population-based study","volume":"82","author":"Sigurgeirsson","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12594-BIB0006|bjd12594-cit-0006","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1365-4362.1997.00349.x","article-title":"Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists\u2019 offices in Ontario, Canada - a multicenter survey of 2001 patients","volume":"36","author":"Gupta","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12594-BIB0007|bjd12594-cit-0007","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1439-0507.2004.00968.x","article-title":"Onychomycosis in Denmark: prevalence of fungal nail infection in general practice","volume":"47","author":"Svejgaard","year":"2004","journal-title":"Mycoses"},{"key":"10.1111\/bjd.12594-BIB0008|bjd12594-cit-0008","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2133.1998.02464.x","article-title":"Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey","volume":"139","author":"Gupta","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12594-BIB0009|bjd12594-cit-0009","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1439-0507.2005.01140.x","article-title":"The nail under fungal siege in patients with type II diabetes mellitus","volume":"48","author":"Pierard","year":"2005","journal-title":"Mycoses"},{"key":"10.1111\/bjd.12594-BIB0010|bjd12594-cit-0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00128071-200001010-00002","article-title":"Onychomycosis. Treatment, quality of life, and economic issues","volume":"1","author":"Elewski","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.12594-BIB0011|bjd12594-cit-0011","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0190-9622(98)70199-9","article-title":"Effect of onychomycosis on quality of life","volume":"38","author":"Drake","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12594-BIB0012|bjd12594-cit-0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/A:1008986826756","article-title":"Measuring the impact of onychomycosis on patient quality of life","volume":"9","author":"Turner","year":"2000","journal-title":"Qual Life Res"},{"key":"10.1111\/bjd.12594-BIB0013|bjd12594-cit-0013","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3122\/15572625-13-4-268","article-title":"Onychomycosis: improved cure rates with itraconazole and terbinafine","volume":"13","author":"Harrell","year":"2000","journal-title":"J Am Board Fam Pract"},{"key":"10.1111\/bjd.12594-BIB0014|bjd12594-cit-0014","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2133.2007.07974.x","article-title":"A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement","volume":"157","author":"Baran","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12594-BIB0015|bjd12594-cit-0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0733-8635(03)00027-5","article-title":"The use of oral antifungal agents to treat onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.12594-BIB0016|bjd12594-cit-0016","unstructured":"Blue Shield of Northeastern New York. Drug therapy guidelines: antifungal agents Lamisil \u00ae (terbinafine), Sporanox \u00ae (itraconazole), Penlac \u00ae (ciclopirox), Vfend \u00ae (voriconazole) Drug P&T Newsletter 2006"},{"key":"10.1111\/bjd.12594-BIB0017|bjd12594-cit-0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"Murdan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1111\/bjd.12594-BIB0018|bjd12594-cit-0018","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2009.03164.x","article-title":"An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis","volume":"23","author":"Baran","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12594-BIB0019|bjd12594-cit-0019","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jaad.2006.12.019","article-title":"Onychomycosis: diagnosis and definition of cure","volume":"56","author":"Scher","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 1","key":"10.1111\/bjd.12594-BIB0020|bjd12594-cit-0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000246182","article-title":"Epidemiology and ecology of onychomycosis","volume":"194","author":"Summerbell","year":"1997","journal-title":"Dermatology"},{"key":"10.1111\/bjd.12594-BIB0021|bjd12594-cit-0021","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/jac\/dkn245","article-title":"In vitro antifungal drug susceptibilities of dermatophytes microconidia and arthroconidia","volume":"62","author":"Coelho","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/bjd.12594-BIB0022|bjd12594-cit-0022","unstructured":"Steifel Laboratories Addendum to Original Medical Officer's Review of NDA 22-484 2010"},{"key":"10.1111\/bjd.12594-BIB0023|bjd12594-cit-0023","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard","author":"CLSI","year":"2008","edition":"2"},{"key":"10.1111\/bjd.12594-BIB0024|bjd12594-cit-0024","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1128\/AAC.38.7.1480","article-title":"Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3,)-\u03b2-d-glucan synthase","volume":"38","author":"Kurtz","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/bjd.12594-BIB0025|bjd12594-cit-0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.70.2.878-888.2002","article-title":"Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces","volume":"70","author":"Kuhn","year":"2002","journal-title":"Infect Immun"},{"key":"10.1111\/bjd.12594-BIB0026|bjd12594-cit-0026","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/02681219480000051","article-title":"Application of neutral red staining for evaluation of the viability of dermatophytes and Candida in human skin scales","volume":"32","author":"Naka","year":"1994","journal-title":"J Med Vet Mycol"},{"key":"10.1111\/bjd.12594-BIB0027|bjd12594-cit-0027","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3314\/jjmm.42.133","article-title":"Observation of tinea unguium by neutral red staining","volume":"42","author":"Aoshim","year":"2001","journal-title":"Nihon Ishinkin Gakkai Zasshi"},{"key":"10.1111\/bjd.12594-BIB0028|bjd12594-cit-0028","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaad.2003.07.011","article-title":"Modulation of linear nail growth to treat diseases of the nail","volume":"50","author":"Geyer","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12594-BIB0029|bjd12594-cit-0029","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7556\/jaoa.1997.97.6.339","article-title":"Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis","volume":"97","author":"Rosso","year":"1997","journal-title":"J Am Osteopath Assoc"},{"key":"10.1111\/bjd.12594-BIB0030|bjd12594-cit-0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/1523-1747.ep12532799","article-title":"The effect of aging on the rate of linear nail growth","volume":"73","author":"Orentreich","year":"1979","journal-title":"J Invest Dermatol"},{"issue":"Suppl. 60","key":"10.1111\/bjd.12594-BIB0031|bjd12594-cit-0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.2001.145s60003.x","article-title":"The future of onychomycosis therapy may involve a combination of approaches","volume":"145","author":"Hay","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12594-BIB0032|bjd12594-cit-0032","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archderm.135.7.852","article-title":"A full \u2018cure\u2019 for onychomycosis is not always possible","volume":"135","author":"Elewski","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12594-BIB0033|bjd12594-cit-0033","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archderm.134.12.1551","article-title":"How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data","volume":"134","author":"Epstein","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12594-BIB0034|bjd12594-cit-0034","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1468-3083.2008.03036.x","article-title":"The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis","volume":"23","author":"Gupta","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12594-BIB0035|bjd12594-cit-0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09546630500504713","article-title":"Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison","volume":"17","author":"Sigurgeirsson","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.12594-BIB0036|bjd12594-cit-0036","article-title":"Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs","author":"Elewski","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12594-BIB0037|bjd12594-cit-0037","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-4362.1998.00360.x","article-title":"Itraconazole for the treatment of onychomycosis","volume":"37","author":"Gupta","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12594-BIB0038|bjd12594-cit-0038","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00128071-200405030-00002","article-title":"Assessing treatment outcomes in toenail onychomycosis clinical trials","volume":"5","author":"Werschler","year":"2004","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl. 56","key":"10.1111\/bjd.12594-BIB0039|bjd12594-cit-0039","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2133.1999.00009.x","article-title":"Long-term outcomes in the treatment of toenail onychomycosis","volume":"141","author":"DeCuyper","year":"1999","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12594","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12594\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:06:43Z","timestamp":1676383603000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/170\/1\/182\/6614997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12594","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}